Detalhe da pesquisa
1.
Immune regulation by CTLA-4--relevance to autoimmune diabetes in a transgenic mouse model.
Diabetes Metab Res Rev
; 27(8): 946-50, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22069290
2.
Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3.
J Immunol
; 181(3): 1683-91, 2008 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18641304
3.
Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86.
Eur J Immunol
; 36(6): 1413-22, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16708397
4.
Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells.
J Immunol
; 174(8): 4803-11, 2005 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15814706
5.
What's the difference between CD80 and CD86?
Trends Immunol
; 24(6): 314-9, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12810107
6.
CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells.
J Immunol
; 172(5): 2778-84, 2004 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14978077
7.
Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells.
Eur J Immunol
; 32(10): 2888-96, 2002 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12355442
8.
Identification of a secondary zinc-binding site in staphylococcal enterotoxin C2. Implications for superantigen recognition.
J Biol Chem
; 279(2): 1297-303, 2004 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-14559915